Spectra for:
José Manuel Blanco, Olga Caamaño, Franco Fernández, José Enrique Rodríguez-Borges, Jan Balzarini, Erik de Clercq
Compound 3 (+/-)-(1-BETA,2-ALPHA,4-BETA)-4-(6-AMINO-9H-PURIN-9-YL)-1,2-CYCLOPENTANEDIMETHANOL
Compound 6 (+/-)-1-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-5-IODO-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE
![(+/-)-1-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-5-IODO-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE](/api/compound/LqlgEjN4fkf.png?h=300&w=458 "(+/-)-1-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-5-IODO-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE")
Compound 7 (+/-)-1-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE
![(+/-)-1-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE](/api/compound/CnVdJNvFFGs.png?h=300&w=458 "(+/-)-1-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE")
Compound 8 (+/-)-1-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-5-IODO-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE
![(+/-)-1-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-5-IODO-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE](/api/compound/CTuOySp5JmV.png?h=300&w=458 "(+/-)-1-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-5-IODO-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE")
Compound 9 (+/-)-6,9-DIHYDRO-9-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1H-PURIN-6-ONE
![(+/-)-6,9-DIHYDRO-9-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1H-PURIN-6-ONE](/api/compound/BLyXIdJbku9.png?h=300&w=458 "(+/-)-6,9-DIHYDRO-9-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1H-PURIN-6-ONE")
Compound 10 (+/-)-(1-BETA,2-ALPHA,4-BETA)-4-(6-CYCLOPROPYLAMINO-9H-PURIN-9-YL)-1,2-CYCLOPENTANEDIMETHANOL
Compound 11 (+/-)-(1-BETA,2-ALPHA,4-BETA)-4-(6-N-ISOPROPYLAMINO-9H-PURIN-9-YL)-1,2-CYCLOPENTANEDIMETHANOL
Compound 12 (+/-)-N-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-N'-(3-ETHOXYPROPENOYL)-UREA
![(+/-)-N-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-N'-(3-ETHOXYPROPENOYL)-UREA](/api/compound/J8nYPjRv349.png?h=300&w=458 "(+/-)-N-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-N'-(3-ETHOXYPROPENOYL)-UREA")
Compound 13 (+/-)-N-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-N'-(3-ETHOXYPROPENOYL)-UREA
![(+/-)-N-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-N'-(3-ETHOXYPROPENOYL)-UREA](/api/compound/9ZQHrIuwNqm.png?h=300&w=458 "(+/-)-N-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-N'-(3-ETHOXYPROPENOYL)-UREA")
Compound 14 (+/-)-1-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE
![(+/-)-1-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE](/api/compound/9vnWVb7y24S.png?h=300&w=458 "(+/-)-1-[(1-BETA,3-ALPHA,4-BETA)-3,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE")
Compound 15 (+/-)-(1-BETA,2-ALPHA,4-BETA)-4-[(5-AMINO-6-CHLOROPYRIMIDIN-4-YL)-AMINO]-1,2-CYCLOPENTANEDIMETHANOL
![(+/-)-(1-BETA,2-ALPHA,4-BETA)-4-[(5-AMINO-6-CHLOROPYRIMIDIN-4-YL)-AMINO]-1,2-CYCLOPENTANEDIMETHANOL](/api/compound/2kekBx1oK70.png?h=300&w=458 "(+/-)-(1-BETA,2-ALPHA,4-BETA)-4-[(5-AMINO-6-CHLOROPYRIMIDIN-4-YL)-AMINO]-1,2-CYCLOPENTANEDIMETHANOL")
Compound 16 (+/-)-(1-BETA,2-ALPHA,4-BETA)-4-(6-CHLORO-9H-PURIN-9-YL)-1,2-CYCLOPENTANEDIMETHANOL
Citation
| Citation | CHEM.PHARM.BULL.,51,1060(2003) |
|---|---|
| Journal | Chemical and Pharmaceutical Bulletin |
| Issue | 9 |
| Volume | 51 |
| Page(s) | 1060-1063 |
| Year | 2003 |
| Author(s) | José Manuel Blanco, Olga Caamaño, Franco Fernández, José Enrique Rodríguez-Borges, Jan Balzarini, Erik de Clercq |
| Publisher | Pharmaceutical Society of Japan |
| DOI | 10.1248/cpb.51.1060 |